Paul W Hawran - Net Worth and Insider Trading
Paul W Hawran Net Worth
The estimated net worth of Paul W Hawran is at least $48 Million dollars as of 2024-06-24. Paul W Hawran is the Executive VP and CFO of Neurocrine Biosciences Inc and owns about 360,144 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $48 Million. Paul W Hawran is also the Director of Plus Therapeutics Inc and owns about 10 shares of Plus Therapeutics Inc (PSTV) stock worth over $18. Details can be seen in Paul W Hawran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul W Hawran has not made any transactions after 2011-09-14 and currently still holds the listed stock(s).
Transaction Summary of Paul W Hawran
Paul W Hawran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul W Hawran owns 3 companies in total, including Plus Therapeutics Inc (PSTV) , Sequenom Inc (SQNM) , and Neurocrine Biosciences Inc (NBIX) .
Click here to see the complete history of Paul W Hawran’s form 4 insider trades.
Insider Ownership Summary of Paul W Hawran
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-09-14 | director |
| SQNM | Sequenom Inc | 2009-03-13 | Chief Financial Officer |
| NBIX | Neurocrine Biosciences Inc | 2006-05-17 | Executive VP and CFO |
Paul W Hawran Latest Holdings Summary
Paul W Hawran currently owns a total of 2 stocks. Among these stocks, Paul W Hawran owns 360,144 shares of Neurocrine Biosciences Inc (NBIX) as of May 17, 2006, with a value of $48 Million and a weighting of 100%. Paul W Hawran also owns 10 shares of Plus Therapeutics Inc (PSTV) as of September 14, 2011, with a value of $18 and a weighting of 0%.
Latest Holdings of Paul W Hawran
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2006-05-17 | 360,144 | 134.58 | 48,468,180 |
| PSTV | Plus Therapeutics Inc | 2011-09-14 | 10 | 1.80 | 18 |
Holding Weightings of Paul W Hawran
Paul W Hawran Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul W Hawran has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 115,481 shares on May 17, 2006, which brought Paul W Hawran around $2 Million.
According to the SEC Form 4 filings, Paul W Hawran has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on September 14, 2011, which cost Paul W Hawran around $16,000.
Insider Trading History of Paul W Hawran
- 1
Paul W Hawran Trading Performance
GuruFocus tracks the stock performance after each of Paul W Hawran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul W Hawran is 40.52%. GuruFocus also compares Paul W Hawran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul W Hawran within 3 months outperforms 6 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul W Hawran's insider trading performs compared to the benchmark.
Performance of Paul W Hawran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.73 | | | | | |
| Relative Return to S&P 500(%) | 22.94 | | | | | |
Paul W Hawran Ownership Network
Paul W Hawran Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
Paul W Hawran is the director of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, Paul W Hawran made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 27,261 shares made by Robert P Lenk , a net purchase of 20,297 shares made by Howard Clowes , and a net purchase of 32,255 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 48,285 shares, with a net purchase of 48,285 shares. During the past 18 months, 2,168 shares of Plus Therapeutics Inc (PSTV) were sold and 103,372 shares were bought by its insiders, resulting in a net purchase of 101,204 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
Paul W Hawran Mailing Address
Above is the net worth, insider trading, and ownership report for Paul W Hawran. You might contact Paul W Hawran via mailing address: 3595 John Hopkins Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
